A. Lembo

发表

The Chicago Classification of Esophageal Motility Disorders , v 3 . 0 International High Resolution Manometry Working Group

A. Bredenoord, R. Mittal, R. Holloway, 2015 .

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

P. Schoenfeld, A. Lembo, M. Pimentel, 2016, Gastroenterology.

Androgen regulation of bowel function in mice and humans

A. Lembo, D. Rastelli, Ariel Robinson, 2020, bioRxiv.

Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.

M. Camilleri, A. Lembo, R. McCallum, 2016, Gastroenterology.

Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders.

Michael Camilleri, Myung-Gyu Choi, Anthony Lembo, 2016, Gastroenterology.

Phase 2b, randomized, double‐blind 12‐week studies of TZP‐102, a ghrelin receptor agonist for diabetic gastroparesis

A. Lembo, R. McCallum, N. Ejskjaer, 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation

T. Kaptchuk, A. Lembo, Mike P Jones, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Complementary and Alternative Medicine Use Is Prevalent Among Patients with Gastrointestinal Diseases

A. Lembo, Adelina Hung, Na-Hoon Kang, 2015, Digestive Diseases and Sciences.

Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus

Henry C. Lin, A. Lembo, M. Pimentel, 2017, The American Journal of Gastroenterology.

Effectiveness of recruitment in clinical trials: an analysis of methods used in a trial for irritable bowel syndrome patients.

Roger B. Davis, T. Kaptchuk, C. Kerr, 2008, Contemporary clinical trials.

Eluxadoline for Irritable Bowel Syndrome with Diarrhea.

L. Turner, A. Lembo, B. Lacy, 2016, The New England journal of medicine.

Complementary and Alternative Medicine in Gastroenterology

A. Lembo, A. Bollom, Andrea Bollom, 2015 .

The Margins

A. Lembo, P. Graziotti, A. Losa, 1996 .

Catechol-O-Methyltransferase val 158 met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome

I. Kirsch, T. Kaptchuk, A. Lembo, 2012 .

A novel endoscopic full-thickness plicator for the treatment of GERD: A pilot study.

R. Chuttani, R. Kozarek, D. Pleskow, 2003, Gastrointestinal endoscopy.

Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results

R. Kozarek, D. Pleskow, R. Rothstein, 2007, Surgical Endoscopy.

Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis

W. Chey, A. Lembo, Lin Chang, 2021, Digestive Diseases and Sciences.

Acute technical feasibility of an endoscopic duodenal-jejunal bypass sleeve in a porcine model: a potentially novel treatment for obesity and type 2 diabetes

A. Lembo, S. Shikora, M. Tarnoff, 2008, Surgical Endoscopy.

Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis

P. Moayyedi, B. Spiegel, A. Ford, 2014, The American Journal of Gastroenterology.

The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis

P. Moayyedi, B. Spiegel, A. Ford, 2014, The American Journal of Gastroenterology.

Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

P. Moayyedi, B. Spiegel, A. Ford, 2014 .

Evaluating the Impact of Cost on the Treatment Algorithm for Chronic Idiopathic Constipation: Cost-Effectiveness Analysis

W. Chey, A. Lembo, C. Siegel, 2021, The American journal of gastroenterology.

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

W. Chey, M. Currie, P. Schoenfeld, 2017, The American Journal of Gastroenterology.

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.

M. Currie, A. Lembo, M. Baird, 2010, Gastroenterology.

Efficacy of linaclotide for patients with chronic constipation.

M. Currie, A. Lembo, J. Johnston, 2010, Gastroenterology.

A 54-year-old woman with constipation-predominant irritable bowel syndrome.

A. Lembo, 2006, JAMA.

The placebo effect in irritable bowel syndrome trials: a meta‐analysis 1

T. Kaptchuk, C. Kerr, W. Stason, 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Improving Medication Tolerance

T. Kaptchuk, A. Lembo, J. Kelley, 2021, Journal of clinical gastroenterology.

Placebo Response in Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.

T. Kaptchuk, A. Lembo, M. Sugarman, 2019, The American journal of gastroenterology.

Chronic in-vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model

A. Lembo, K. Gersin, S. Shikora, 2008, Surgical Endoscopy.

The Clinical and Economic Burden of Irritable Bowel Syndrome

A. Lembo, 2007 .

Endoscopic full-thickness plication for the treatment of GERD: Five-year long-term multicenter results

R. Hawes, R. Kozarek, D. Pleskow, 2008, Surgical Endoscopy.

Can an Evidence-Based Approach Improve the Patient-Physician Relationship?

A. Lembo, A. Davis, A. Cifu, 2020, JAMA.

Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study

T. Kaptchuk, A. Lembo, S. Ballou, 2022, BMC psychology.

Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome.

A. Lembo, Suma Magge, 2012, Gastroenterology & hepatology.

Efficacy and Safety of Tradipitant in Diabetic and Idiopathic Gastroparesis: A Randomized, Placebo-Controlled Study.

M. Polymeropoulos, H. Parkman, T. Abell, 2020, medRxiv.

Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome

I. Kirsch, T. Kaptchuk, A. Lembo, 2022, Psychosomatic medicine.

Safety of Endoscopy in Heritable Connective Tissue Disorders.

A. Lembo, K. Mukamal, J. Nee, 2019, The American journal of gastroenterology.

Irritable bowel syndrome: evaluation and treatment.

A. Lembo, S. C. Somers, S. Somers, 2003, Gastroenterology clinics of North America.

Scientific Updates The Council President Message

A. Lembo, 2012 .

Reduction in pain: Is it worth the gain? The effect of opioids on the GI tract

A. Lembo, J. Nee, V. Rangan, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Peripheral Opioids for Functional GI Disease: A Reappraisal

A. Lembo, 2006, Digestive Diseases.

Opioid-Induced Bowel Dysfunction

A. Lembo, G. Ketwaroo, V. Cheng, 2013, Current Gastroenterology Reports.

Opioid-induced bowel dysfunction

A. Lembo, Howard Y. Chang, 2008, Current treatment options in gastroenterology.

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D

E. Alm, A. Lembo, J. Kelley, 2022, Gut microbes.

The Zelnorm epidemiologic study (ZEST): a cohort study evaluating incidence of abdominal and pelvic surgery related to tegaserod treatment

B. Kuo, A. Walker, A. Lembo, 2012, BMC Gastroenterology.

Alosetron in Irritable Bowel Syndrome

A. Lembo, F. Farraye, H. Weber, 2012, Drugs.

Chronic Constipation [4] (multiple letters)

M. Camilleri, A. Lembo, F. Cadeddu, 2004 .

Complementary and alternative medicine and CBT in gastroenterology

A. Lembo, S. Ballou, J. Katon, 2022, Yamada's Textbook of Gastroenterology.

Efficacy and Safety of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial.

M. Polymeropoulos, H. Parkman, T. Abell, 2020, Gastroenterology.

Prevalence of Functional GI Diseases and Pelvic Floor Symptoms in Marfan Syndrome and Ehlers-Danlos Syndrome

A. Lembo, J. Kelley, S. Ballou, 2019, Journal of clinical gastroenterology.

Successful Treatment with Methylnaltrexone and IVIG for Paraneoplastic Syndrome-Associated Intestinal Pseudo-Obstruction.

R. Chuttani, T. Berzin, A. Lembo, 2013, Gastroenterology & hepatology.

A Treatment Trial of Acupuncture in IBS Patients

Roger B. Davis, D. Drossman, T. Kaptchuk, 2009, The American Journal of Gastroenterology.

Microbiome and Its Role in Irritable Bowel Syndrome

A. Lembo, M. Pimentel, 2020, Digestive Diseases and Sciences.

Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome

P. Moayyedi, A. Ford, G. Ianiro, 2022, Alimentary pharmacology & therapeutics.

Letter: efficacy of peppermint oil in irritable bowel syndrome—authors' reply

P. Moayyedi, A. Ford, G. Ianiro, 2022, Alimentary pharmacology & therapeutics.

Developing Valid and Reliable Health Utilities in Irritable Bowel Syndrome: Results From the IBS PROOF Cohort

W. Chey, B. Spiegel, R. Bolus, 2009, The American Journal of Gastroenterology.

Human Studies of Motility and Sensation : Utility in Drug Development for Functional Gastrointestinal Disorders

M. Camilleri, A. Lembo, Myung-Gyu Choi, 2016 .

Editorial: latent class analysis to improve confidence in the diagnosis of IBS

A. Lembo, S. Ballou, 2017, Alimentary pharmacology & therapeutics.

Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome

I. Kirsch, T. Kaptchuk, A. Lembo, 2010, PloS one.

Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial.

Roger B. Davis, I. Kirsch, T. Kaptchuk, 2021, Pain.

Effects of treatment with eluxadoline on abdominal pain in patients with IBS‐D: Additional post hoc analyses of Phase 3 trials

A. Lembo, P. Covington, D. Andrae, 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Review Article Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation

M. Camilleri, L. Webster, A. Lembo, 2016 .

Consensus Recommendations on Initiating Prescription Therapies for Opioid‐Induced Constipation

M. Camilleri, L. Webster, A. Lembo, 2015, Pain medicine.

Complementary and alternative medicine for the irritable bowel syndrome.

A. Lembo, Suma Magge, 2011, Gastroenterology clinics of North America.

Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C

M. Currie, S. Shiff, A. Lembo, 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation

D. Drossman, M. Currie, A. Lembo, 2009, The American Journal of Gastroenterology.

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.

I. Lowy, A. Lembo, L. Davidson, 2008, Vaccine.

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials.

K. Olden, A. Lembo, A. Heath, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice

A. Lembo, D. Rastelli, Ariel Robinson, 2021, The Journal of clinical investigation.

Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach.

A. Lembo, S. Dorn, F. Cremonini, 2014, American journal of gastroenterology supplements.

Pharmacologic , Pharmacokinetic , and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders

M. Camilleri, A. Lembo, Myung-Gyu Choi, 2016 .

Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013

A. Lembo, S. Ballou, J. Nee, 2017, Journal of clinical gastroenterology.

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014

A. Lembo, S. Flier, A. Cheifetz, 2018, Alimentary pharmacology & therapeutics.

Effects of the vibrating capsule on colonic circadian rhythm and bowel symptoms in chronic idiopathic constipation

W. Chey, E. Quigley, A. Lembo, 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

A. Lembo, S. Ballou, J. Nee, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial

A. Lembo, M. Pimentel, B. Cash, 2017, Therapeutic advances in gastroenterology.

Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients

Roger B. Davis, I. Kirsch, T. Kaptchuk, 2014, Brain and behavior.

Fecal Incontinence and Diarrhea During Pregnancy

A. Lembo, A. Charabaty, S. Menees, 2022, The American journal of gastroenterology.

Irritable Bowel Syndrome: An Infectious Disease?

A. Lembo, E. Quigley, 2017, Gastroenterology.

Discontinued products, uncertain data, changing options: Selecting effective and reliable treatment for IBS

W. Chey, P. Schoenfeld, A. Lembo, 2008 .

CHRONICALLY QUESTIONED ABOUT CHRONIC CONSTIPATION

A. Lembo, 2007 .

NEW AND NOVEL PHARMACOLOGIC THERAPIES FOR CHRONIC CONSTIPATION

A. Lembo, 2006 .

Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013

A. Lembo, S. Ballou, J. Nee, 2017, Journal of clinical gastroenterology.

Small Intestinal Bacterial Overgrowth Breath Testing in Gastroenterology: Clinical Utility and Pitfalls.

A. Lembo, J. Nee, V. Rangan, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Congenital Sucrase-Isomaltase Deficiency: What, When, and How?

W. Chey, A. Lembo, B. Cash, 2020 .

Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation

A. Lembo, S. Ballou, J. Nee, 2020, Journal of clinical gastroenterology.

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

A. Lembo, Lin Chang, B. Lacy, 2019, Therapeutic advances in gastroenterology.

Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report

P. Whorwell, D. Drossman, L. Chang, 2011, The American Journal of Gastroenterology.

Predictors of positive endoscopic findings in hospitalized patients with occult gastrointestinal bleeding

A. Lembo, E. Tapper, N. Sengupta, 2015 .

Symptom Severity, Mood, and Healthcare Use Are Associated With Satisfaction in Patients With Irritable Bowel Syndrome.

A. Lembo, S. Ballou, J. Nee, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Irritable Bowel Syndrome Medications Side Effects Survey

A. Lembo, 2004, Journal of clinical gastroenterology.

Prospective evaluation of multilayered epithelium in Barrett's esophagus

B. Ransil, R. Odze, A. Lembo, 2001, American Journal of Gastroenterology.

Fecal Urgency: Clinical and Manometric Characteristics in Patients With and Without Diarrhea

A. Lembo, S. Ballou, J. Nee, 2020, Digestive Diseases and Sciences.

Fecal urgency is common in constipated patients and is associated with anxiety

A. Lembo, S. Ballou, J. Nee, 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Chronic constipation.

Michael Camilleri, Anthony Lembo, M. Camilleri, 2003, The New England journal of medicine.

Immunological and Clinical Study in Patients after Spermatic Cord Torsion

A. Lembo, C. Betterle, R. Zanchetta, 2009, Andrologia.

Particular imaging features and customized thermal ablation treatment for intramedullary osteoid osteoma in pediatric patients

A. Lembo, A. Leone, A. Campana, 2011, Skeletal Radiology.

“Maybe I Made Up the Whole Thing”: Placebos and Patients’ Experiences in a Randomized Controlled Trial

T. Kaptchuk, C. Kerr, A. Lembo, 2009, Culture, medicine and psychiatry.

Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome

J. Loscalzo, T. Kaptchuk, Rui-Sheng Wang, 2022, Frontiers in Pain Research.

Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results.

A. Lembo, R. Hurle, A. Losa, 2000, The Journal of urology.

Intravesical Instillation of Mitomycin-C in 242 Patients with Superficial Bladder Cancer at High Risk of Recurrence: Long-Term Results

A. Lembo, E. Micheli, A. Losa, 1999, Urologia Internationalis.

Bowel Disorders.

R. Spiller, W. Chey, A. Lembo, 2016, Gastroenterology.

End‐to‐end urethroplasty: long‐term results

A. Lembo, E. Micheli, G. Peracchia, 2002, BJU international.

Primary actinomycosis of the urachus

A. Lembo, E. Micheli, A. Losa, 1999, BJU international.

Treatment of Helicobacter pylori infection with intra‐gastric violet light phototherapy: A pilot clinical trial

Michael R Hamblin, D. Cave, S. Sheth, 2009, Lasers in surgery and medicine.

syndrome controlled trial in patients with irritable bowel Components of placebo effect: randomised

Roger B. Davis, D. Drossman, I. Kirsch, 2008 .

Use of serum biomarkers in a diagnostic test for irritable bowel syndrome

B. Neri, A. Lembo, D. Barken, 2009, Alimentary pharmacology & therapeutics.

Linaclotide Significantly Improved Abdominal Pain, Constipation and Global Assessments in Adults with Irritable Bowel Syndrome with Constipation: Results from a Large Twelve-Week, Randomized, Double-Blind, Placebo-Controlled Study

M. Currie, A. Lembo, M. Baird, 2008 .

Review of tegaserod in the treatment of irritable bowel syndrome

A. Lembo, Sonal Patel, D. Berrada, 2004, Expert opinion on pharmacotherapy.

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

W. Chey, A. Lembo, M. Pimentel, 2011, The New England journal of medicine.

The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review

P. Moayyedi, B. Spiegel, A. Ford, 2015, Clinical and Translational Gastroenterology.

American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome.

A. Lembo, Lin Chang, S. Sultan, 2014, Gastroenterology.

American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

P. Moayyedi, B. Spiegel, A. Ford, 2014, The American Journal of Gastroenterology.

Influence of genetics on irritable bowel syndrome, gastro‐oesophageal reflux and dyspepsia: a twin study

N. Talley, A. Lembo, Michael P. Jones, 2007, Alimentary pharmacology & therapeutics.

An evaluation of the FDA Responder Endpoint for IBS‐C clinical trials: analysis of data from linaclotide Phase 3 clinical trials

L. Nelson, M. Currie, S. Shiff, 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Mo2054 Assessing Abdominal and Bowel Symptoms Using Adequate Relief Based Thresholds: Results From 2 Phase 3 Trials of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

M. Camilleri, M. Currie, S. Shiff, 2013 .

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

W. Chey, M. Currie, S. Shiff, 2012, The American Journal of Gastroenterology.

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

M. Currie, S. Shiff, A. Lembo, 2012, The American Journal of Gastroenterology.

American Gastroenterological Association medical position statement on constipation.

A. Lembo, A. Bharucha, S. Dorn, 2013, Gastroenterology.

Emergency Department Burden of Constipation in the United States from 2006 to 2011

A. Lembo, Michael P. Jones, J. Kelley, 2015, The American Journal of Gastroenterology.

Low dose Pasteur bacillus Calmette-Guerin regimen in stage T1, grade 3 bladder cancer therapy.

A. Lembo, P. Graziotti, A. Losa, 1996, The Journal of urology.

Two randomized trials of linaclotide for chronic constipation.

M. Currie, S. Shiff, A. Lembo, 2011, The New England journal of medicine.

Randomised clinical trial: effects of MD‐7246 on irritable bowel syndrome with diarrhoea

B. Kuo, A. Lembo, R. Boinpally, 2022, Alimentary pharmacology & therapeutics.

Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints

W. Chey, A. Lembo, S. Menees, 2022, Canadian journal of gastroenterology & hepatology.

Irritable Bowel Syndrome: Pathophysiology and Goals of Therapy

A. Lembo, M. Pimentel, B. Cash, 2020 .

Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis

M. Currie, S. Shiff, A. Lembo, 2019, Expert review of gastroenterology & hepatology.

Chronic Constipation

W. Chey, M. Camilleri, A. Ford, 1928, Nature Reviews Disease Primers.

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial

M. Currie, S. Shiff, A. Lembo, 2015, PloS one.

The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials

M. Currie, L. Chang, S. Shiff, 2014, Alimentary pharmacology & therapeutics.

Motility disorders of the colon and rectum

A. Lembo, Suma Magge, B. Gras, 2013, Current opinion in gastroenterology.

Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial.

W. Chey, A. Lembo, J. Johanson, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome

I. Kirsch, T. Kaptchuk, A. Lembo, 2012, PloS one.

The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome

A. Awais, S. Sheth, A. Lembo, 2013, Alimentary pharmacology & therapeutics.

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.

A. Lembo, Lin Chang, S. Sultan, 2022, Gastroenterology.

Spontaneous closure of vesicouterine fistula after cesarean section.

A. Lembo, W. Artibani, P. Graziotti, 1978, The Journal of urology.

Functional Bowel Disease

W. Chey, B. Kuo, A. Lembo, 2017, The American Journal of Gastroenterology.

Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis.

A. Lembo, D. Leffler, C. Kelly, 2009, Gastroenterology.

Diagnostic testing for dyssynergic defecation in chronic constipation: meta‐analysis

A. Lembo, E. Videlock, F. Cremonini, 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

P. Moayyedi, A. Ford, E. Soffer, 2014, The American Journal of Gastroenterology.

Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects

G. Barlow, A. Lembo, M. Pimentel, 2015, PloS one.

Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain

J. Bernstein, A. Lembo, K. Staller, 2022, Journal of clinical gastroenterology.

Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits

M. Camilleri, A. Lembo, D. Katzka, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Development and Validation of the Rome IV Diagnostic Questionnaire for Adults

Lin Chang, William D. Chey, Henry P. Parkman, 2016 .

Irritable bowel syndrome and diet

P. Portincasa, A. Lembo, S. Ballou, 2017, Gastroenterology report.

Management of irritable bowel syndrome with diarrhea: focus on eluxadoline

A. Lembo, B. Lacy, L. Kuritzky, 2021, Current medical research and opinion.

Surgical Treatment of Renal Cell Carcinoma with Vena Cava Or Cavo-Atrial Involvement. Our Experience

A. Lembo, P. Ferrazzi, I. Ghidoni, 1992 .

Chronic Diarrhea and Constipation are More Common in Depressed Individuals.

A. Lembo, S. Ballou, J. Nee, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders

A. Lembo, Rafla Hassan, S. Ballou, 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Clinical and psychological factors predict outcome in patients with Functional Dyspepsia: A prospective study.

A. Lembo, Rafla Hassan, S. Ballou, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study

A. Lembo, S. Ballou, J. Nee, 2020, Digestive Diseases and Sciences.

Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic

Eaman Alhassan, A. Lembo, S. Ballou, 2018, Digestive Diseases and Sciences.

Letter: seasonality in eosinophilic oesophagitis and food bolus obstruction – what about recurrent episodes? – Authors’ reply

A. Lembo, E. Tapper, N. Sengupta, 2015, Alimentary pharmacology & therapeutics.

T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response

A. Lembo, M. Pimentel, Y. Ringel, 2008 .

Abdominal pain in irritable bowel syndrome

Emeran A. Mayer, Bruce D. Naliboff, Anthony Lembo, 1999 .

New and Emerging Treatment Options for Irritable Bowel Syndrome.

W. Chey, A. Lembo, B. Lacy, 2015, Gastroenterology & hepatology.

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS

A. Lembo, F. Cremonini, E. Chuang, 2012, Alimentary pharmacology & therapeutics.

Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials

W. Chey, B. Spiegel, L. Chang, 2010, Alimentary pharmacology & therapeutics.

Rifaximin Significantly Improves Quality of Life Versus Placebo in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: 1182

W. Chey, N. Talley, A. Lembo, 2008 .

Linaclotide Significantly Improved Bowel Habits and Relieved Abdominal Symptoms in Adults with Chronic Constipation: Data from a Large 4-Week, Randomized, Double-Blind, Placebo-Controlled Study

D. Drossman, M. Currie, A. Lembo, 2008 .

Diagnosing irritable bowel syndrome: no more million dollar work-up?

A. Lembo, F. Cremonini, V. Cheng, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials

W. Chey, L. Chang, P. Schoenfeld, 2014, Alimentary pharmacology & therapeutics.

Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.

A. Lembo, M. Pimentel, K. Chong, 2012, The American journal of medicine.

Rifaximin for the treatment of irritable bowel syndrome

A. Lembo, F. Cremonini, 2012, Expert opinion on pharmacotherapy.

Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009

A. Lembo, Michael P. Jones, S. Nurko, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome

W. Chey, A. Fodor, A. Lembo, 2018, Gut microbes.

Meta‐analysis: the effects of placebo treatment on gastro‐oesophageal reflux disease

T. Kaptchuk, A. Lembo, J. Kelley, 2010, Alimentary pharmacology & therapeutics.

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial

Roger B. Davis, T. Kaptchuk, M. Dossett, 2015, PloS one.

Tu1390 Improvement in Quality of Life of Patients With Irritable Bowel Syndrome With Diarrhea is Sustained for 10 Weeks Following a 2-Week Course of Rifaximin

A. Lembo, M. Pimentel, Lin Chang, 2012 .

Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients.

A. Lembo, A Losa, R Hurle, 1999, Urology.

Autosomal recessive form of whistling face syndrome in sibs.

A. Giannotti, B. Dallapiccola, A. Lembo, 1989, American journal of medical genetics.

Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey.

M. Camilleri, A. Lembo, A. Shin, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Management of ureteral calculi and DRG

A. Lembo, R. Hurle, A. Ranieri, 1997 .

Editorial: IBS With Constipation, Functional Constipation, Painful and Non-Painful Constipation: e Pluribus…Plures?

A. Lembo, F. Cremonini, 2014, The American Journal of Gastroenterology.

The clinical predictors of aetiology and complications among 173 patients presenting to the Emergency Department with oesophageal food bolus impaction from 2004–2014

A. Lembo, E. Tapper, D. Leffler, 2015, Alimentary pharmacology & therapeutics.

Dig Dis Sci (2011) 56:2639–2645 DOI 10.1007/s10620-011-1801-0 ORIGINAL ARTICLE Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic

H. Parkman, A. Lembo, J. Johanson, 2022 .

Current gut-directed therapies for irritable bowel syndrome

A. Lembo, E. Kelly, Howard Y. Chang, 2006, Current treatment options in gastroenterology.

Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C

L. Nelson, M. Camilleri, M. Currie, 2015, United European gastroenterology journal.

The Clinical Accuracy of the BÜHLMANN fCAL ELISA in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Multicenter Prospective Case–Control Study

R. Arsenescu, P. Higgins, A. Bousvaros, 2019, Crohn's & Colitis 360.

The international anorectal physiology working group (IAPWG) recommendations: Standardized testing protocol and the London classification for disorders of anorectal function

W. Chey, R. Farouk, W. Whitehead, 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians.

Lin Chang, Jan Tack, P. Whorwell, 2016, Gastroenterology.

Pathogenesis of Persistent infertility in Men after Varicocelectomy

A. Lembo, C. Foresta, G. Ruzza, 1983, Andrologia.

Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.

A. Lembo, Prashant Singh, 2021, Gastroenterology clinics of North America.

Difference in Defecation Desire Between Patients With and Without Chronic Constipation: A Large-Scale Internet Survey

A. Nakajima, A. Lembo, T. Higurashi, 2020, Clinical and translational gastroenterology.

CTG-20-0178 1..5

A. Nakajima, A. Lembo, T. Higurashi, 2022 .

Clinical and manometric characteristics of women with paradoxical puborectalis syndrome

A. Lembo, S. Ballou, J. Nee, 2018, United European gastroenterology journal.

Efficacy of Treatments for Opioid‐Induced Constipation: Systematic Review and Meta‐analysis

A. Lembo, S. Sultan, M. Sugarman, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Patient and Practitioner Influences on the Placebo Effect in Irritable Bowel Syndrome

Ted J. Kaptchuk, Irving Kirsch, John M. Kelley, 2009, Psychosomatic medicine.

Gender differences in chronic constipation on anorectal motility

B. Kuo, A. Lembo, J. Nee, 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Tegaserod Does not Alter Fasting or Meal-Induced Biliary Tract Motility

W. Chey, R. Fisher, C. Beglinger, 2004, American Journal of Gastroenterology.

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

P. Schoenfeld, A. Lembo, M. Pimentel, 2017, Digestive Diseases and Sciences.

Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M)

A. Lembo, J. Nee, 2021, Alimentary pharmacology & therapeutics.

Complementary and Alternative Medicine Use by US Adults With Gastrointestinal Conditions: Results from the 2012 National Health Interview Survey

Roger B. Davis, M. Dossett, A. Lembo, 2014, The American Journal of Gastroenterology.

Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome

P. Marquis, A. Lembo, A. Nishida, 2014, Clinical and Translational Gastroenterology.

Managing irritable bowel syndrome

W. Whitehead, A. Lembo, B. Horwitz, 2003 .

Measuring irritable bowel syndrome patient‐reported outcomes with an abdominal pain numeric rating scale

W. Chey, B. Spiegel, L. Chang, 2009, Alimentary pharmacology & therapeutics.

Dysphagia Worsens With Increasing Ineffective Swallows Among Patients With Ineffective Esophageal Motility

A. Lembo, D. Leiman, J. Nee, 2022, Journal of clinical gastroenterology.

Spasm, nutcracker, and IEM: real or manometry findings?

A. Lembo, T. Konturek, 2008, Journal of clinical gastroenterology.

Pseudoachalasia Secondary to Thoracic Aortic Aneurysm.

A. Lembo, M. Kent, J. Beqari, 2017, The Annals of thoracic surgery.

Diagnosis and Medical Management of Other Esophageal Motility Disorders

A. Lembo, W. Hirsch, M. Zakari, 2019, The SAGES Manual of Foregut Surgery.

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.

A. Lembo, A. Losa, R. Hurle, 1999, Urology.

Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship.

T. Kaptchuk, A. Lembo, E. Macklin, 2010, Social science & medicine.

Prevalence of Chronic Constipation and Chronic Diarrhea in Diabetic Individuals in the United States

A. Lembo, S. Ballou, J. Nee, 2019, The American Journal of Gastroenterology.

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.

A. Lembo, Lin Chang, S. Sultan, 2022, Gastroenterology.

Inpatient Burden of Constipation in the United States: An Analysis of National Trends in the United States from 1997 to 2010

A. Lembo, Mike P Jones, V. Wadhwa, 2014, The American Journal of Gastroenterology.

Significant Morbidity and Mortality Associated with Fecal Impaction in Patients Who Present to the Emergency Department

A. Lembo, S. Ballou, J. Nee, 2018, Digestive Diseases and Sciences.

Fecal Impaction in the Emergency Department: An Analysis of Frequency and Associated Charges in 2011

A. Lembo, Mike P Jones, N. Sengupta, 2016, Journal of clinical gastroenterology.

Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross‐sectional analysis of the 2009‐2010 National Health and Nutrition Examination Survey

A. Lembo, S. Ballou, J. Nee, 2019, Alimentary pharmacology & therapeutics.

The Prevalence of Gastroesophageal Reflux in Patients With Excessive Central Airway Collapse

A. Majid, A. Lembo, F. Kheir, 2019, Chest.

[Conservative surgery of parenchymal renal carcinoma: urologic data from Lombardy].

A. Lembo, E. Micheli, D. Belussi, 1997, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Investigating placebo effects in irritable bowel syndrome: a novel research design.

Roger B. Davis, L. Lasagna, I. Kirsch, 2006, Contemporary clinical trials.

Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data

M. Camilleri, A. Lembo, R. McCallum, 2020, Alimentary pharmacology & therapeutics.

Renzapride in IBS: is efficacy in the eye of the beholder? author’s reply

A. Lembo, 2010 .

Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation – a double‐blind, randomized, placebo‐controlled, study

A. Lembo, F. Cremonini, R. Hickling, 2010, Alimentary pharmacology & therapeutics.

Irritable bowel syndrome: toward an understanding of severity.

Anthony Lembo, D. Drossman, A. Lembo, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Decrease of ultrasound estimated bladder weight during tamsulosin treatment in patients with benign prostatic enlargement.

A. Lembo, D. Belussi, G. Borgonovo, 2002, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

Belching

A. Lembo, S. Ballou, J. Nee, 2021, Journal of clinical gastroenterology.

Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction, Based on IBS in America Survey.

M. Camilleri, A. Lembo, A. Shin, 2019, Gastroenterology.

Editorial: symptom improvement does not equal satisfaction with treatment for constipation

A. Lembo, S. Ballou, 2020, Alimentary pharmacology & therapeutics.

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial

Roger B. Davis, I. Kirsch, T. Kaptchuk, 2017, Trials.

Serum correlates of the placebo effect in irritable bowel syndrome

T. Kaptchuk, A. Lembo, J. Kelley, 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

A meta‐analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome

T. Kaptchuk, W. Stason, A. Lembo, 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Clinical Characteristics of Patients Presenting With Bloating as a Predominant Symptom

A. Lembo, S. Ballou, J. Nee, 2022, Journal of clinical gastroenterology.

Symptom severity and clinical characteristics of patients with bloating

A. Lembo, S. Ballou, J. Nee, 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice

W. Chey, B. Spiegel, L. Chang, 2010, Alimentary pharmacology & therapeutics.

Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.

J. Almenoff, R. Fogel, A. Lembo, 2013, Gastroenterology.

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use

W. Chey, A. Lembo, B. Cash, 2017, The American Journal of Gastroenterology.

Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States

A. Lembo, S. Ballou, J. Nee, 2018, The American Journal of Gastroenterology.

OC-070 Eluxadoline Demonstrates Efficacy for the Treatment of Irritable Bowel Syndrome (IBS) with Diarrhoea (IBS-D) Among Multiple Clinically Relevant Patient Subgroups

W. Chey, A. Lembo, B. Lacy, 2016 .

Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome

J. Loscalzo, T. Kaptchuk, A. Lembo, 2022, Frontiers in Psychiatry.

Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome

G. Barlow, A. Lembo, M. Pimentel, 2017, Digestive Diseases and Sciences.

Duodenal fat intensifies the perception of heartburn

J. Elashoff, J. Meyer, E. Mayer, 2001, Gut.

Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D

A. Lembo, J. Silvester, D. Duerksen, 2019, United European gastroenterology journal.

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study

M. Freedman, J. Wolinsky, T. Ziemssen, 2020, CNS Drugs.

Intraduodenal fat alters perceptual and autonomic responses to acid perfusion of the esophagus in GERD patients

B. Naliboff, J. Munakata, E. Mayer, 1998 .

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)

W. Chey, A. Lembo, D. Rosenbaum, 2020, The American journal of gastroenterology.

NOTES: Transvaginal Endoscopic Cholecystectomy in Humans—Preliminary Report of a Case Series

R. Parthasarathi, D. Drossman, T. Kaptchuk, 2009, The American Journal of Gastroenterology.

Racial and Ethnic Disparities in Opioid Prescriptions in Benign and Malignant Pancreatic Disease in the United States

S. Freedman, A. Lembo, J. Nee, 2022, Pancreas.

Emergency Department Burden of Diverticulitis in the USA, 2006–2013

A. Lembo, J. Nee, W. Hirsch, 2017, Digestive Diseases and Sciences.

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)

W. Chey, A. Lembo, D. Rosenbaum, 2020, The American journal of gastroenterology.

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial

W. Chey, A. Lembo, D. Rosenbaum, 2017, The American Journal of Gastroenterology.

Characterizing Normal Bowel Frequency and Consistency in a Representative Sample of Adults in the United States (NHANES)

A. Lembo, Z. Jiang, S. Ballou, 2018, The American Journal of Gastroenterology.

Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo‐controlled trial (CAPTIVATE)

A. Lembo, B. Cash, Lin Chang, 2023, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome

A. Lembo, J. Nee, M. Zakari, 2015, Expert opinion on pharmacotherapy.

Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized, sham-controlled trial.

Kenneth J. Chang, C. Lightdale, R. Kozarek, 2006, Gastroenterology.

Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue.

P. Brigidi, R. Budriesi, P. Ioan, 2006, World journal of gastroenterology.

Congenital curvature of the penis. Results of nesbit's operation in 29 cases

A. Lembo, G. Breda, F. Pagano, 1984 .

Tegaserod provides rapid and sustained relief of constipation, abdominal bloating/distension, and abdominal discomfort/pain in patients with chronic constipation

W. Chey, A. Lembo, G. Tougas, 2003 .

Safety and tolerability of tegaserod in patients treated for chronic constipation (CC): A 12-week, double-blind, placebo-controlled multicenter study performed in the americas

W. Chey, A. Lembo, J. Johanson, 2003 .

What is the impact of Tegaserod on gallbladder emptying?

R. Fisher, A. Lembo, V. Shi, 2003, American Journal of Gastroenterology.

Prevalence and Associated Factors of Bloating: Results from the Rome Foundation Global Epidemiology Study.

B. Löwe, O. Palsson, S. Bangdiwala, 2023, Gastroenterology.

Risk Factors for Fecal Urgency Among Individuals With and Without Diarrhea, Based on Data From the National Health and Nutrition Examination Survey

A. Lembo, S. Ballou, J. Nee, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders

A. Lembo, S. Ballou, J. Nee, 2021, American Journal of Gastroenterology.

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

A. Lembo, M. Pimentel, Z. Heimanson, 2020, Clinical and translational gastroenterology.

How Would You Manage This Patient With Recurrent Diverticulitis?

A. Lembo, R. Burns, J. Nee, 2023, Annals of Internal Medicine.

Do Patients Understand the Bristol Stool Scale? Results of Cognitive De-Briefing of IBS Patients

W. Chey, B. Spiegel, R. Bolus, 2011 .

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

D. Drossman, I. Kirsch, T. Kaptchuk, 2008, BMJ : British Medical Journal.

929d Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety

J. Almenoff, A. Lembo, J. M. Davenport, 2014 .

929a A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis

M. Camilleri, A. Lembo, R. McCallum, 2014 .

Neurotrophin-3 Improves Functional Constipation

D. Drossman, J. Cedarbaum, N. Stambler, 2003, American Journal of Gastroenterology.

I7. The Effect of Naloxegol on Stool Consistency in Patients with Noncancer Pain and Opioid‐Induced Constipation

L. Webster, A. Lembo, M. Sostek, 2017 .

the Effect Of Naloxegol On Stool Consistency In Patients With Noncancer Pain And Opioid-induced Constipation : wip16–0379

L. Webster, A. Lembo, M. Sostek, 2016 .

Psychiatric Disorder, Irritable Bowel Syndrome, and Extra-Intestinal Symptoms in a Population-Based Sample of Twins

R. Krueger, A. Lembo, F. Creed, 2009, The American Journal of Gastroenterology.

Patient information: Fecal incontinence

A. Lembo, 2004 .

Current Diagnostic Strategies and Pharmacologic Treatment Options for Irritable Bowel Syndrome

A. Lembo, 2007 .

Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial.

S. Lo, R. Hawes, R. Kozarek, 2004, Gastrointestinal endoscopy.

American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation

Christopher V. Almario, W. Chey, A. Lembo, 2023, The American journal of gastroenterology.

Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia

A. Lembo, S. Ballou, J. Nee, 2019, Journal of neurogastroenterology and motility.

Editorial: mixed soluble fibre in chronic constipation – something new?

A. Lembo, J. Nee, 2016, Alimentary pharmacology & therapeutics.

Evolving concepts in chronic constipation in Europe and elsewhere: not worlds apart

A. Lembo, F. Cremonini, G. Chiarioni, 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

HOW TO IDENTIFY , COUNSEL , AND TREAT PATIENTS WITH CHRONIC CONSTIPATION AND IRRITABLE BOWEL SYNDROME * —

A. Lembo, 2006 .

Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial.

S. Lo, R. Hawes, R. Kozarek, 2005, Gastrointestinal endoscopy.

286 Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

M. Currie, S. Shiff, A. Lembo, 2010 .

In‐patient discharge rates for the irritable bowel syndrome – an analysis of national trends in the United States from 1997 to 2010

A. Lembo, Michael P. Jones, V. Wadhwa, 2013, Alimentary pharmacology & therapeutics.

Endoscopic full-thickness plication for GERD: 12-month multi-center study results

S. Lo, R. Hawes, R. Kozarek, 2003, American Journal of Gastroenterology.

Tu1401 Factors Contributing to Treatment Satisfaction in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Treated With Linaclotide vs Placebo

M. Currie, S. Shiff, A. Lembo, 2012 .

Sa1098 Mediation Analysis Supports a Direct Effect of Linaclotide on Relief of Abdominal Pain Independent of Constipation Improvement

D. Mackinnon, M. Currie, S. Shiff, 2012 .

Understanding the Placebo and Nocebo Effects in Patients With Irritable Bowel Syndrome.

A. Lembo, 2020, Gastroenterology & hepatology.

The Plicator Procedure for the Treatment of GERD: 12-Month Multicenter Results

D. Pleskow, A. Lembo, F. Maluf-Filho, 2005 .

Postural epigastric pain: A unique symptom of primary cytomegalovirus gastritis?

A. Lembo, M. Giladi, B. Johnson, 1998, Infection.

Long‐term Follow‐up of Peyronie's Disease: Reporting 41 Cases

A. Lembo, G. Breda, W. Artibani, 1984 .

Varicocele and infertility. Preoperative prognostic elements

A. Lembo, C. Foresta, G. Ruzza, 1984 .

Up-front endoscopy maximizes cost-effectiveness and cost-satisfaction in uninvestigated dyspepsia.

W. Chey, A. Lembo, B. Moshiree, 2023, Clinical Gastroenterology and Hepatology.

10‐biomarker algorithm to identify irritable bowel syndrome: authors’ reply

A. Lembo, H. Pan, 2009 .

American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.

Christopher V. Almario, W. Chey, A. Lembo, 2023, Gastroenterology.

Efficacy and Safety of Once Daily Linaclotide in Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Followed by a 4-Week Randomized Withdrawal Period

S. Shiff, A. Lembo, J. Johnston, 2011 .

475i Rifaximin Treatment for 2 Weeks Provides Acute and Sustained Relief Over 12 Weeks of IBS Symptoms in Non-Constipated Irritable Bowel Syndrome: Results From 2 North American Phase 3 Trials (Target 1 and Target 2)

W. Chey, A. Lembo, M. Pimentel, 2010 .

Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating

R. Kerstens, A. Lembo, K. Staller, 2021, The American journal of gastroenterology.

Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

P. Schoenfeld, A. Lembo, M. Pimentel, 2017, Digestive Diseases and Sciences.

Stool frequency a subjective endpoint in ulcerative colitis and irritable bowel syndrome clinical trials. Comparison between stool frequency and mucosal healing from study with Interferon-B-1a

P. Mannon, A. Lembo, F. Cataldi, 2011 .

Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population

D. Drossman, A. Lembo, K. Lasch, 2017, Therapeutic advances in gastroenterology.

Development of a New Instrument to Assess Stool Form and Consistency in Irritable Bowel Syndrome with Diarrhea

P. Marquis, A. Lembo, K. Lasch, 2016 .

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

M. Currie, S. Shiff, A. Lembo, 2012, The American Journal of Gastroenterology.

Information- and Health-care Seeking Behaviors in Patients With Irritable Bowel Syndrome.

M. Camilleri, A. Lembo, A. Shin, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Editorial: topiramate for cyclic vomiting syndrome—for refractory patients only?

A. Lembo, V. Rangan, 2021, Alimentary pharmacology & therapeutics.

Bowel Disorders.

R. Spiller, W. Chey, A. Lembo, 2016, Gastroenterology.

Serum correlates of the placebo effect in irritable bowel syndrome

A. Lembo, E. Kokkotou, M. Quilty, 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

W. Chey, A. Lembo, M. Pimentel, 2011, The New England journal of medicine.

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.

M. Currie, A. Lembo, M. Baird, 2010, Gastroenterology.

Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis.

A. Lembo, D. Leffler, C. Kelly, 2008, Gastroenterology.